Cancer chemopreventive pharmacology of phytochemicals derived from plants of dietary and non-dietary origin: implication for alternative and complementary approaches

Phytochemistry Reviews

Volumn 13, Issue 4, 2014, Pages 811-833

  Ullah, Mohammad F ^a   Bhat, Showket H ^a   Husain, Eram ^a   Abu Duhier, Faisel ^a   Hadi, S M ^b   Sarkar, Fazlul H ^c   Ahmad, Aamir ^c  

^a UNIVERSITY OF TABUK   (Saudi Arabia)

^b ALIGARH MUSLIM UNIVERSITY   (India)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative and complementary therapy; Chemoprevention; Phytochemicals

Indexed keywords

ASCORBIC ACID; BETA ELEMENE; CURCUMIN; CURCUMOL; CYANIDIN 3 O RUTINOSIDE; DAIDZEIN; DELPHINIDIN; DELTA ELEMENE; ELLAGIC ACID; FARNESOL; FURANODIENE; FURANODIENONE; GENISTEIN; GERMACRONE; GNIDIMACRIN; GRAPE SEED EXTRACT; ISOFLAVONE DERIVATIVE; NIGELLA SATIVA EXTRACT; ORIDONIN; PLANT MEDICINAL PRODUCT; POMEGRANATE EXTRACT; QUERCETIN; RESVERATROL; RUTOSIDE; SOYBEAN EXTRACT; SULFORAPHANE; TERPENOID DERIVATIVE; THYMOQUINONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSOLIC ACID;

ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BERRY; BREAST ADENOCARCINOMA; BROCCOLI; CANCER PREVENTION; CANCER RISK; CELL CYCLE ARREST; CHEMOPROPHYLAXIS; CHINESE MEDICINE; CITRUS FRUIT; COLON TUMOR; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG STRUCTURE; ESOPHAGEAL ADENOCARCINOMA; FAMILIAL COLON POLYPOSIS; GRAPE; HUMAN; LUNG TUMOR; MEDICINAL PLANT; NONHUMAN; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHYTOCHEMISTRY; POMEGRANATE; POMEGRANATE JUICE; PROSTATE CANCER; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REVIEW; RISK REDUCTION; SKIN TUMOR; SOYBEAN;

EID: 84912035754     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-014-9341-9     Document Type: Review

References (239)

1. ACS guidelines (2013) On nutrition and physical activity for cancer prevention. www.cancer.org/. Accessed 12 Mar 2013
2. Adhami VM, Khan N, Mukhtar H (2009) Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutr Cancer 61:811–815
3. Adlercreutz H (1995) Phytoestrogens: epidemiology and possible role in cancer prevention. Environ Health Perspect 103:103–112
4. Adlercreutz H (2002) Phytoestrogens and cancer. Lancet Oncol 3:364–373
5. Adlercreutz H, Honjo H, Ahigashi A (1991) Urinary excretion of lignins and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional diet. Am J Clin Nutrition 54:1093–1100
6. Adlercreutz H, Goldin BR, Gorbach SL, Hockerstedt K et al (1995) Soybean phytoestrogens intake and cancer risk. J Nutr 125:757S–770S
7. Agarwal C, Singh RP, Agarwal R (2002) Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release. Carcinogenesis 23:1869–1876
8. Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71:1397–1421
9. Aggarwal BB, Bhardwaj A, Aggarwal RS (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783–2840
10. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA et al (2005) Curcumin suppresses the paclitaxel-induced nuclear factor-kappa B pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11:7490–7498
11. Ahmad A, Biersack B, Li Y, Kong D, Bao B, Schobert R, Padhye SB, Sarkar FH (2013a) Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy. Anticancer Agents Med Chem 13:1002–1013
12. Ahmad A, Biersack B, Li Y, Kong D, Bao B, Schobert R, Padhye SB, Sarkar FH (2013b) Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment. Anticancer Agents Med Chem 13:1014–1024
13. Ahmad A, Biersack B, Li Y, Bao B, Kong D, Ali S, Banerjee S, Sarkar FH (2013c) Perspectives on the role of isoflavones in prostate cancer. AAPS J 15:991–1000
14. Ahmad A, Li Y, Bao B, Kong D, Sarkar FH (2014) Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals. Mol Nutr Food Res 58:79–86
15. Albrecht M, Jiang W, Kumi-Diaka J et al (2000) Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food 7:274–283
16. Ambrosone CB, McCann SE, Freudenheim JL, Marshall JR, Zhang Y, Shields PG (2004) Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr 134:1134–1138
17. Aziz MH, Kumar R, Ahmad N (2003) Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms. Int J Oncol 23:17–28
18. Aziz MH, Reagan-Shaw S, Wu J, Longley BJ, Ahmad N (2005) Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? J FASEB 19:1193–1195
19. Badary OA, Taha RA, Gamal el-Din AM, Abdel-Wahab MH (2003) Thymoquinone is a potent superoxide anion scavenge. Drug Chem Toxicol 26:87–98
20. Banerjee S, Li Y, Wang Z, Sarkar FH (2008) Multi-targeted therapy of cancer by genistein. Cancer Lett 269:26–242
21. Banerjee S, Kaseb AO, Wang Z et al (2009) Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Res 69:5575–5583
22. Barile E, Borriello M, Di Pietro A, Doreau A, Fattorusso C, Fattorusso E, Lanzotti V (2008) Discovery of a new series of jatrophane and lathyrane diterpenes as potent and specific P-glycoprotein modulators. Org Biomol Chem 6:1756–1762
23. Bishayee A, Ahmed S, Brankov N, Perloff M (2011) Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Front Bios 16:980–996
24. Bissery MC, Guénard D, Guéritte-Voegelein F et al (1991) Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51:4845–4852
25. Biswas S, Ray M, Misra S, Dutta DP, Ray S (1997) Selective inhibition of mitochondrial respiration and glycolysis in human leukemic leukocytes by methylglyoxal. Biochem J 323:248–343
26. Block G (1991) Vitamin C and cancer prevention: the epidemiologic evidence. AmJ Clin Nutr 53:270S–282S
27. Bourgou S, Ksouri R, Bellila A, Skandrani I, Falleh H, Marzouk B (2008) Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots. C R Biol 331:48–55
28. Brouet I, Ohshima H (1995) Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Com 206:533–540
29. Burke YD, Ayoubi AS, Werner SR (2002) Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. Anticancer Res 22:3127–3134
30. Cal CG, Jazirehi H, Yeh A, Mizutani Y, Bonavida B (2003) Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr Med Chem Anti-Cancer Agents 3:77–93
31. Cameron E, Pauling L (1978) Supplemental ascorbate in the supportive treatment of cancer: re-evaluation of prolongation of survival times in terminal human cancers. PNAS 75:4538–4542
32. Cao F, Jin TY, Zhou YF (2006) Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene. Biomed Environ Sci 19:35–41
33. Carvalho CR, Fonseca MR (2006) Carvone: why and how should one bother to produce this terpene. Food Chem 95:413–422
34. Castonguay A, Gali HU, Perchellet EM (1997) Antitumorigenic and antipromoting activities of ellagic acid, ellagitannins and oligometric anthocyanin and procyanidin. Int J Oncol 10:367–373
35. Cecchinato V, Chiaramonte R, Nizzardo M, Cristofaro B, Basile A et al (2007) Resveratrol induced apoptosis in human Tcell acute lymphoblastic leukemia MOLT-4 cells. Biochem Pharmacol 74:1568–1574
36. Chang KL, Cheng HL, Huang LW et al (2009) Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line. Cancer Lett 276:14–20
37. Chaturvedi PK, Bhui K, Shukla Y (2008) Lupeol: connotations for chemoprevention. Cancer Lett 263:1–13
38. Chauhan DP (2002) Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des 8:1695–1706
39. Chen F, Castranova V, Shi X, Demers LM (1995) New insights into the role of nuclear factor-k B, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45:7–17
40. Chen P, Stone J, Sullivan G, Drisko JA, Chen Q (2011) Anti-cancer effect of pharmacologic ascorbate and its interaction with supplementary parenteral glutathione in preclinical cancer models. Free Rad Biol Med 51:681–687
41. Christine MK, Milner JA (2011) Herbs and spices in cancer prevention and treatment. In: Benzei IFF, Wachtel-Galor S (eds) Herbal medicine: biomolecular and clinical aspects, 2nd edn. CRC Press, Boca Raton (FL)
42. Chung FL, Conaway CC, Rao CV, Reddy BS (2000) Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulphoraphane and phenethyl isothiocyanate. Carcinogenesis 21:2287–2291
43. Clarke JD, Dashwood RH, Ho E (2008) Multi-targeted prevention of cancer by sulphoraphane. Cancer Lett 269:291–304
44. Cohen M, Bhagavan HN (1995) Ascorbic acid and gastrointestinal cancer. J Am Coll Nutr 14:565–578
45. Cohen JH, Kristal AR, Stanford JL (2000) Fruit and vegetable intakes and prostate cancer risk. J Nat Cancer Inst 92:61–68
46. Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS et al (1991) Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enz Reg 31:385–389
47. Corea G, Di Pietro A, Dumontet C, Fattorusso E, Lanzotti V (2009) Jatrophane diterpenes from Euphorbia spp. as modulators of multidrug resistance in cancer therapy. Phytochem Rev 8:431–447
48. Cornblatt BS, Ye L, Dinkova-Kostova AT, Erb M, Fahey JW et al (2007) Preclinical and clinical evaluation of sulphoraphane for chemoprevention in the breast. Carcinogenesis 28:1485–1490
49. Creagen ET, Moertal CG, O’Fallon JR et al (1979) Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: a controlled trial. NEJM 301:687–900
50. Crowell PL (1999) Prevention and therapy of cancer by dietary monoterpenes. J Nutr 129:775S–778S
51. Cruz-Correa M, Shoskes DA, Sanchez P et al (2006) Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 4:1035–1038
52. Cvorovic J, Tramer F, Granzotto M, Candussio L, Decorti GS (2010) Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. Arch Biochem Biophys 501:151–157
53. Dashwood RH, Ho E (2007) Dietary histone deacetylase inhibitors: from cells to mice to man. Sem Cancer Biol 17:363–369
54. Dashwood RH, Ho E (2008) Dietary agents as histone deacetylase inhibitors. Nutr Rev 66:S36–S38
55. de Kok TM, van Breda SG, Manson MM (2008) Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr 2:51–59
56. Dinkova-Kostova AT, Jenkins SN, Fahey JW et al (2006) Protection against UV-light—induced skin carcinogenesis in SKH-1 high-risk mice by sulphoraphane-containing broccoli sprout extracts. Cancer Lett 240:243–252
57. Donaldson MS (2004) Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutrition 3:3–19
58. Drake IM, Davies MJ, Mapstone NP et al (1996) Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis 17:559–562
59. Durak I, Cetin R, Devrim E, Erguder IB (2005) Effects of black grape extract on activities of DNA turn-over enzymes in cancerous and non-cancerous human colon tissues. Life Sci 76:2995–3000
60. El-Mahdy MA, Zhu Q, Wang QE, Wani G et al (2005) Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int J Cancer 117:409–417
61. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK (2002) Sulphoraphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. PNAS 99:7610–7615
62. Farah IO, Begum RA (2003) Effect of Nigella sativa (N. sativa L.) and oxidative stress on the survival pattern of MCF-7 breast cancer cells. Biomed Sci Instrument 39:359–364
63. Fauzee NJ, Dong Z, Wang Y (2012) Taxanes: promising anti-cancer drugs. APJCP 12:837–851
64. Fowke JH, Chung FL, Jin F et al (2003) Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res 63:3980–3986
65. Francesca S, Giusy S, Giulia S, Paola S, Nicoletta S et al (2003) Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. J FASEB 17:2339–2341
66. Fulda S (2009) Betulinic acid: a natural product with anticancer activity. Mol Nutr Food Res 53:140–146
67. Gali-Muhtasib H, Diab-Assaf M, Boltze C, Al-Hmaira J et al (2004a) Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol 25:857–866
68. Gali-Muhtasib HU, Abou Kheir WG, Kheir LA, Darwiche N et al (2004b) Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs 15:389–399
69. Gen news highlights (2010) Abraxis reports phase III success with abraxane in first-line NSCLC. http://www.genengnews.com/gen-news-highlights/abraxisreports-phase-III-success-with-abraxane-in-first-linensclc/81243495/. Accessed 4 Nov 2010
70. Ghosheh OA, Houdi AA, Crooks PA (1990) High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J Pharm Biomed Analysis 19:757–762
71. Gould MN (1997) Cancer chemoprevention and therapy by monoterpenes. Environ Health Perspect 105:977–979
72. Greco AM, Gentile M, Di Filippo O, Coppola A (1982) Study of blood vitamin C in lung and bladder cancer patients before and after treatment with ascorbic acid: a preliminary report. Acta Vitaminol Enzymol 4:155–162
73. Grif K (2000) Estrogens and prostatic disease. Prostate 45:87–100
74. Griner EM, Kazanietz MG (2007) Protein Kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7:281–294
75. Gullet NP, Amin MR, Bayraktar S et al (2010) Cancer prevention with natural compounds. Semin Oncol 37:258–281
76. Gupta VS, Zhang H, Banerjee S, Kong D, Raffoul JJ, Sarkar FH et al (2009) Radiation-induced HIF-1 alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. Int J Cancer 124:1675–1684
77. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
78. Harris GK, Gupta A, Nines RG, Kresty LA, Habib SG, Frankel WL et al (2001) Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2-deoxyguanosine levels in the Fischer 344 rat. NutrCancer 40:125–133
79. Heath DD, Khwaja FF, Rock CL (2004) Curcumin content of turmeric and curry powders. J FASEB 18:A125
80. Hecht SS, Huang C, Stoner GD, Li J, Kenney PM, Sturla SJ et al (2006) Identification of cyanidin glycosides as constituents of freeze-dried black raspberries which inhibit anti-benzo[a]pyrene-7,8-diol-9,10-epoxide-induced NF kappaB and AP-1 activity. Carcinogenesis 27:1617–1626
81. Herbert J, Hurley T, Olendzki B, Teas J, Yunsheng M et al (1998) Nutritional and socio-economic factors in relation to prostate cancer mortality: a cross-national study. J Nat Cancer Inst 90:1637–1647
82. Hewitt AL, Singletary K (2003) Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model. Cancer Lett 192:133–143
83. Hou DX, Ose T, Lin S et al (2003) Anthocyanidins induce apoptosis in human promyelocytic leukemia cells: structure–activity relationship and mechanisms involved. Int J Oncol 23:705–712
84. Howe GR, Burch JD (1996) Nutrition and pancreatic cancer. Cancer Causes Control 7:69–82
85. Huang MT, Wang ZY, Georgiadis CA, Laskin JD, Conney AH (1992) Inhibitory effect of curcumin on tumor initiation by benzo[a]pyrene and 7,12- dimethylbenz[a]anthracene. Carcinogenesis 13:2183–2186
86. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR et al (1994) Inhibitory effect of dietary curcumin on forestomach, duodenal and colon carcinogenesis in mice. Cancer Res 54:5841–5847
87. Huang C, Li J, Song L, Zhang D, Tong Q, Ding M et al (2006) Black raspberry extracts inhibit benzo(a)pyrene diol-epoxide-induced activator protein 1 activation and VEGF transcription by targeting the phosphotidylinositol 3-kinase/Akt pathway. Cancer Res 66:581–587
88. Huang J, Wu L, Tashiro S, Onodera S, Ikejima T (2008) Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways. J Pharmacol Sci 107:370–379
89. Huang M, Lu JJ, Huang MQ, Bao JL, Chen XP, Wang YT (2012) Terpenoids: natural products for cancer therapy. Expert Opin Invest Drugs 21:1801–1818
90. Ingram D, Sanders K, Kolybaba M, Lopez D (1997) Casecontrol study of phyto-oestrogens and breast cancer. Lancet 350:990–994
91. Jang M, Cai L, Udeani GO et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220
92. Jin CY, Moon DO, Lee JD, Heo MS et al (2007a) Sulphoraphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells. Carcinogenesis 28:1058–1066
93. Jin CY, Park C, Cheong JH et al (2007b) Genistein sensitizes TRAIL-resistant human gastric adenocarcinoma AGS cells through activation of caspase-3. Cancer Lett 257:56–64
94. Jin CY, Park C, Kim GY, Lee SJ, Kim WJ, Choi YH (2009) Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Chemico-Biol Interact 180:43–150
95. Joe B, Vijaykumar M, Lokesh BR (2004) Biological properties of curcumin—cellular and molecular mechanisms of action. Critic Rev Food Sci Nutr 44:97–111
96. Johnson JJ, Nihal M, Siddiqui IA et al (2011) Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 55:1169–1176
97. Joseph MA, Moysich KB, Freudenheim JL et al (2004) Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr Cancer 50:206–213
98. Kaseb A, Chinnakannu K, Chen D, Sivanandam A et al (2007) Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone refractory prostate cancer. Cancer Res 67:7782–7788
99. Kathleen A (1998) Ascorbic acid in the prevention and treatment of cancer. Alternative Med Rev 3:174–186
100. Kaur M, Singh RP, Gu M, Agarwal R, Agarwal C (2006) Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells. Clin Cancer Res 12:6194–6202
101. Kaur M, Agarwal C, Agarwal R (2009) Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. J Nutr 139:1806S–1812S
102. Khader M, Bresgen N, Eckl PM (2010) Antimutagenic effects of ethanolic extracts from selected Palestinian medicinal plants. J Ethnopharmacol 127:319–324
103. Khan MA, Carducci MA, Partin AW (2003) The evolving role of docetaxel in the management of androgen independent prostate cancer. J Urol 170:1709–1716
104. Khan N, Afaq F, Kweon KK, Mukhtar H (2007) Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res 67:3475–3482
105. Khan N, Adhami V, Mukhtar H (2009) Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr RelatCancer 17:39–52
106. Khan N, Afaq F, Mukhtar H (2010) Lifestyle as risk factor for cancer: evidence from human studies. Cancer Lett 293:133–143
107. Khan MA, Chen HC, Tania M, Zhang DZ (2011) Anticancer activities of Nigella sativa (black cumin). Afr J Trad Complem Alter Med 8:226–232
108. Khanduja KL, Avti PK, Kumar S, Mittal N, Sohi KK, Pathak CM (2006) Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: a Bcl-2 independent mechanism. Biochim Biophys Acta 1760:283–289
109. Khaw KT, Bingham S, Welch A (2001) Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. Lancet 357:657–663
110. Kim YK, Yoon SK et al (2000) Cytotoxic triterpenes from stem bark of physocarpus intermediu. Planta Med 68:392–936
111. Kim ND, Mehta R, Yu W et al (2002) Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 71:203–217
112. Kim YA, Lee WH, Choi TH, Rhee SH, Park KY et al (2003) Involvement of p21/WAF1WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells. Int J Oncol 23:1143–1149
113. King AA, Leszczynska J, Hickey CA, Klein CB (2006) Prevention of spontaneous and X-ray induced genomic instability in breast cancer cells by the dietary anti-mutagens genistein and lycopene. Environ Mol Mutagen 47:45–52
114. Kohno H, Suzuki R, Yasui Y et al (2004) Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats. Cancer Sci 95:481–486
115. Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A et al (2006) Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol Cancer Ther 5:621–629
116. Kresty LA, Morgan C, Carlton PS, Lu J, Gupta A, Blackwood M et al (2001) Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 61:6112–6119
117. Kris-Etherton PM, Hecker KD, Bonanome A et al (2002) Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 113:71S–88S
118. Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199–225
119. Kuo PL, Chiang LC, Lin CC (2002) Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 72:23–34
120. Lanzotti V, Termolino P, Dolci M, Curir P (2012) Paviosides A–H, eight new oleane type saponins from Aesculus pavia with cytotoxic activity. Bioorg Med Chem 20:3280–3286
121. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE (1991) Dietary effects on breast cancer risk in Singapore. Lancet 336:1197–1200
122. Lee KW, Bode AM, Dong Z (2011) Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 11:211–218
123. Lee HJ, Khor TO, Shu L, Su ZY, Fuentes F, Kong ANT (2013) Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacol Therapeutics 137:153–171
124. Levine M, Rumsey SC, Daruwala R, Park JB, Wang Y (1999) Criteria and recommendations for vitamin C intake. JAMA 281:1415–1423
125. Li M, Zhang Z, Hill DL, Chen X, Wang H, Zhang R (2005a) Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels. Cancer Res 65:8200–8208
126. Li TM, Chen GW, Su CC et al (2005b) Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res 25:971–979
127. Li X, Wang G, Zhao J et al (2005c) Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2–M phase. Cell Mol Life Sci 62:894–904
128. Li Y, Liu J, Liu X, Xing K, Wang Y et al (2006) Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9. Appl Biochem Biotechnol l35:181–192
129. Liby KT, Yore MM, Sporn MB (2007) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer 7:357–369
130. London SJ, Yuan JM, Chung FL et al (2000) Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 356:724–729
131. Longtin R (2003) The pomegranate: nature’s power fruit? J Nat Cancer Inst 95:346–348
132. Lu JJ, Dang YY, Huang M, Chen XP, Wang YT (2012) Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae—a review. J Ethnopharmacol 143:406–411
133. Mabrouk GM, Moselhy SS, Zohny SF et al (2002) Inhibition of methylnitrosourea (MNU) induced oxidative stress and carcinogenesis by orally administered bee honey and Nigella grains in Sprague Dawely rats. J Exp Clin Cancer Res 21:341–346
134. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN et al (2005) Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. PNAS 102:14813–14818
135. Mangal M, Sagar P, Singh H, Raghav G, Agarwal SM (2013) NPACT: naturally occurring plant-based anti-cancer compound-activity-target database. Nucleic Acids Res 41:1124–1129
136. Marks PA, Xu WS (2009) Histone deacetylase inhibitors: potential in cancer therapy. J Cell Biochem 107:600–608
137. Matsui TA, Sowa Y, Yoshida T, Murata H et al (2006) Sulphoraphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells. Carcinogenesis 27:1768–1777
138. Matsui TA, Murata H, Sakabe T, Sowa Y, Horie N, Nakanishi R et al (2007) Sulphoraphane induces cell cycle arrest and apoptosis in murine osteosarcoma cells in vitro and inhibits tumor growth in vivo. Oncol Report 18:1263–1268
139. McCormick WJ (1954) Cancer: the preconditioning factor in pathogenesis. Arch Pediatr 71:313–322
140. McCormick WJ (1959) Cancer: a collagen disease, secondary to a nutritional deficiency? Arch Pediatr 76:166–171
141. Menon VP, Sudheer AR (2007) Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595:105–125
142. Messin MJ, Wood CE (2008) Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J 7:17
143. Messina MJ (2003) Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr Rev 61:117–131
144. Mettlin C, Graham S, Priore R et al (1981) Diet and cancer of the esophagus. Nutr Cancer 2:143–147
145. Miller PE, Snyder DC (2012) Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr Clin Prac 27:599–612
146. Milner JA (1994) Reducing the risk of cancer. In: Goldberg I (ed) Functional foods: designer foods, pharma foods, nutraceuticals. Chapman and Hall, New York, pp 39–62
147. Moertal CG, Fleming TR, Creagen ET, Rubin AJ, O’Connell MJ, Ames MM (1985) High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double blind comparison. NEJM 312:137–141
148. Monti DA, Mitchell E, Bazzan AJ et al (2012) Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS ONE 7:e29794
149. Mooi LY, Yew WT, Hsum YW et al (2012) Suppressive effect of maslinic acid on PMA-induced protein kinase C in human B-lymphoblastoid cells. APJCP 13:1177–1182
150. Morishige F, Murata A (1979) Prolongation of survival times in terminal human cancer by administration of supplemental ascorbate. J Int AcadPrev Med 5:47–52
151. Mullauer FB, Kessler JH, Medema JP (2010) Betulinic acid, a natural compound with potent anticancer effects. Anticancer Drugs 21:215–227
152. Myzak MC, Karplus PA, Chung FL, Dashwood RH (2004) A novel mechanism of chemoprotection by sulphoraphane: inhibition of histone deacetylase. Cancer Res 64:5767–5774
153. Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH (2006) Sulphoraphone inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc min mice. FASEB J 20:506–508
154. Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E (2007) Sulphoraphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med 232:227–234
155. Nabell L, Spencer S (2003) Docetaxel with concurrent radiotherapy in head and neck cancer. Sem Oncol 30:89–93
156. Omaya TS, Scala JH, Jacob RA (1986) Plasma ascorbic acid in adult males: effects of depletions and supplementation. J Am Coll Nutr 44:257–264
157. Ong TP, Heidor R, de Conti A, Dagli ML, Moreno FS (2006) Farnesol and geraniol chemopreventive activities during the initial phases of hepato-carcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis 27:1194–1203
158. Padayatty SJ, Sun H, Wang Y et al (2004) Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Inter Med 140:533–537
159. Pantuck AJ, Leppert JT, Zomorodian N et al (2006a) Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 12:4018–4026
160. Pantuck AJ, Zomorodian N, Belldegrun AS (2006b) Phase-II Study of pomegranate juice for men with prostate cancer and increasing PSA. Curr Urol Rep 7:7–13
161. Park OJ, Sur YJ (2004) Chemopreventive potential of epigallo-catechin-gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett 150:43–56
162. Patel KR, Brown VA, Jones DJ et al (2010) Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70:7392–7399
163. Pathak AK, Bhutani M, Nair AS et al (2007) Ursolic Acid Inhibits STAT3 Activation Pathway Leading to Suppression of Proliferation and Chemosensitization of Human Multiple Myeloma Cells. Mol Cancer Res 5:943–955
164. Patlolla JM, Rao CV (2012) Triterpenoids for cancer prevention and treatment: current status and future prospectives. Curr Pharma Biotechno 13:147–155
165. Patwardhan B, Warude D, Pushpangadan P, Bhatt N (2005) Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med 2:465–473
166. Pavese JM, Farmer RL, Berga RC (2010) Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastat Rev 29:465–482
167. Pazdur R (2005) Cancer drug information. http://www.cancer.gov/cancertopics/druginfo/fda-nanoparticle-paclitaxel. Accessed 3 Nov 2010
168. Pham NA, Jacobberger JW, Schimmer AD, Cao P, Gronda M, Hedley DW (2004) The dietary isothiocyanate sulphoraphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immune deficient mice. Molr Cancer Ther 3:1239–1248
169. Poppel G, Verhoeven DT, Verhagen H, Goldbohm RA (1999) Brassica vegetables and cancer prevention: epidemiology and mechanisms. Adv Exp Med Biol 472:159–168
170. Prasad S, Yadav VR, Sung B et al (2012) Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin Cancer Res 15:4942–4953
171. Qazi A, Pal J, Maitah M et al (2010) Anticancer activity of a broccoli derivative, sulphoraphane, in Barrett Adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy. Trans Oncol 3:389–399
172. Rabi T, Gupta S (2008) Dietary terpenoids and prostate cancer chemoprevention. Front Bios 13:3457–3469
173. Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH (2006) Hillman GG (2006) Genistein inhibits radiation-induced activation of NF-kappaBin prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 6:107
174. Raffoul JJ, Banerjee S, Che M, Knoll ZE, Doerge DR, Abrams J (2007) Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model. Int J Cancer 120:2491–2498
175. Reddy BS, Wang CX, Samaha H et al (1997) Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res 57:420–425
176. Rodrigo K, Rawal Y, Renner R, Schwartz S, Tian Q, Larsen P et al (2006) Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries. Nutr Cancer 54:58–68
177. Roepke M, Diestel A, Bajbouj K, Walluscheck D et al (2007) Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol Ther 6:160–169
178. Rooney S, Ryan MF (2005) Modes of action of alpha-hederin and thymoquinone, active consituents of Nigella sativa against Hep-2 cancer cells. Anticancer Res 25:4255–4259
179. Ross HA, McDougall GJ, Stewart D (2007) Antiproliferative activity is predominantly associated with ellagitannins in raspberry extracts. Phytochemistry 68:218–228
180. Roth AD, Ajani J (2003) Docetaxel-based chemotherapy in the treatment of gastric cancer. Ann Oncol 14:41–44
181. Sayed-Ahmed MM, Aleisa AM, Salim S, Al-Rejaie SS et al (2010) Thymoquinone attenuates diethylnitrosamine induction of hepatic carcinogenesis through antioxidant signaling. Oxid Med Cell Long 3:254–261
182. Schorah CJ, Sobala GM, Collis N, Primrose J (1991) Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis. Am J Clin Nutr 53:287S–293S
183. Seeram NP (2008) Berry fruits for cancer prevention: current status and future prospects. J Agri Food Chem 56:630–635
184. Seeram NP, Adams LS, Henning SM et al (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16:360–367
185. Sethi G, Ahn KS, Aggarwal BB (2008) Targeting nuclear factor-κB activation pathway by thymoquinone: role in suppression of anti-apoptotic gene products and enhancement of apoptosis. Mol Cancer Res 6:1059–1070
186. Shan JZ, Xuan YY, Zheng S, Dong Q, Zhang SZ (2009) Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway. J Zhejiang Univ Sci B10:668–674
187. Shanmugam MK, Ong TH, Kumar AP et al (2012) Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. PLoS ONE 7:e32476
188. Shih A, Zhang S, Cao HJ, Boswell S, Wu YH et al (2004) Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha. Mol Cancer Therap 3:1355–1364
189. Shishodia S, Majumdar S, Banerjee S, Aggarwal BB (2003) Ursolic acid inhibits nuclear factor-kappa B activation induced by carcinogenic agents through suppression of I kappa-Balpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 63:4375–4383
190. Shoieb AM, Elgayyar M, Dudrick PS, Bell JL et al (2003) In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol 22:107–113
191. Sidhu GS, Singh AK, Thaloor D, Banaudha KK, Patnaik GK et al (1998) Enhancement of wound healing by curcumin in animals. Wound Rep Reg 6:167–177
192. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29
193. Singh S, Aggarwal BB (1995) Activation of transcription factor NF-kB is suppressed by curcumin (diferuloylmethane). J Biol Chem 270:24995–25000
194. Singh SV, Hu X, Srivastava SK, Singh M, Xia H et al (1998) Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis 19:1357–1360
195. Singh RP, Tyagi AK, Dhanalakshmi S, Agarwal R, Agarwal C (2004) Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein- 3. Int J Cancer 108:733–740
196. Sloan AE (2005) Top 10 global food trends. Food Technol 59:20–32
197. Sobala GM, Pignaetelli B, Schorah CJ et al (1991) Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 12:193–198
198. Sporn MB, Suh N (2002) Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2:537–543
199. Stoner GD, Sardo C, Apseloff G, Mullet D, Wargo W, Pound V et al (2005) Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries for 7 days. J Clin Pharmacol 45:1153–1164
200. Stoner GD, Wang LS, Zikri N et al (2007) Cancer prevention with freeze-dried berries and berry components. Sem Cancer Biol 17:403–410
201. Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ (2000) Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cell. Cancer Res 60:2399–2404
202. Sun XY, Zheng YP, Lin DH, Zhang H, Zhao F, Yuan CS (2009) Potential anti- cancer activities of Furanodiene, a Sesquiterpene from Curcuma wenyujin. Am J Chinese Med 37:589–596
203. Surh YJ (1999) Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mut Res 428:305–327
204. Surh YJ, Chun KS (2007) Cancer chemopreventive effects of curcumin. Adv Exp Med Biol 595:149–172
205. Syed DN, Afaq F, Mukhtar H (2007) Pomegranate derived products for cancer prevention. Semin Cancer Biol 17:377–385
206. Tannock IF, Wit RD, Berry WR et al (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. NEJM 351:1502–1512
207. Thabrew MI, Mitry RR, Morsy MA, Hughes RD (2005) Cytotoxic effects of a decoction of Nigella sativa, Hemidesmus indicus and Smilax glabra on human hepatoma HepG2 cells. Life Sci 77:1319–1330
208. Thoppil RJ, Bishayee A (2011) Terpenoids as potential chemopreventive and therapeutic agents in liver cancer. World J Hepatol 3:228–249
209. Touny E, Banerjee LH (2006) Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the Cdc-2/CyclinB1 complex and growth inhibition of TRAMP-C2 cancer cells by genistein. Prostate 66:1542–1555
210. Ullah MF, Bhat SH, Hussain E, Abu-Duhier F, Ahmad A, Hadi SM (2012) Ascorbic acid in cancer chemoprevention: translational perspectives and efficacy. Currt Drug Targets 13:1757–1771
211. Ulrich S, Wolter F, Stein JM (2005) Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol NutrFood Res 49:452–461
212. Ulrich S, Loitsch SM, Rau O, Knethen A, Brüne B et al (2006) Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Res 66:7348–7354
213. Vallinas MG, Castejón MG, Casado AR, Molina RD (2013) Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives. Nutr Rev 71:585–599
214. Vigushin DM, Poon GK, Boddy A (1998) Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer research campaign phase I/II clinical trials committee. Cancer Chemother Pharmacol 42:111–117
215. Wang LS, Stoner GD (2008) Anthocyanins and their role in cancer prevention. Cancer Lett 269:281–290
216. Wang HZ, Zhang Y, Xie LP, Zhang RQ (2002) Effects of genistein and daidzein on the cell growth, cell cycle, and differentiation of human and murine melanoma cells. J Nutr Biochemi 13:421–426
217. Wang G, Li X, Huang F (2005) Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 62:881–893
218. Wang Z, Desmoulin S, Banerjee S et al (2008) Synergistic effects of multiple natural products in pancreatic cancer cells. Life Sci 83:293–300
219. Wang X, Zhang F, Yang L et al (2011) Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J Biomed Biotechnol 2011:419343
220. Wani MC, Taylor HL, Wall ME et al (1971) Plant antitumor agents: the isolation and structure of taxol, a novel anti-leukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93:2325–2327
221. WHO (2002) WHO traditional medicine strategy 2002–2005. World Health Organization, Geneva
222. Wiseman H, Casey K, Bowey EA et al (2004) Influence of 10 wk soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora in healthy adults. Am J Clin Nutr 8:692–699
223. World Health Organization. Cancer fact sheet. February 2011. Accessed March 30, 2012. http://www.who.int/mediacentre/factsheets/fs297/en/index.html
224. Wu HJ, Chan WH (2007) Genistein protects methylglyoxal-induced oxidative damage and cell injury in human mononuclear cells. Toxicol In Vitro 21:335–342
225. Wu Q, Koponen J, Mykkanen H, Torronen R (2007) Berry phenolic extracts modulate the expression of p21waf1 and Bax but not Bcl-2 in HT-29 colon cancer cells. J Agri Food Chem 55:156–1163
226. Xiao JX, Huang GQ, Geng X, Qiu HW (2011) Soy-derived isoflavones inhibit HeLa cell growth by inducing apoptosis. Plant Foods Hum Nutr 66:122–128
227. Xu L, Bian K, Liu Z, Zhou J, Wang G (2005) The inhibitory effect of the curcumol on women cancer cells and synthesis of RNA. Tumor 25:570–572
228. Yi T, Cho SG, Yi Z et al (2008) Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 7:1789–1796
229. Yoshida M, Matsui Y, Iizuka A, Ikarashi Y (2009) G2-phase arrest through p21(WAF1/Cip1) induction and cdc2 repression by gnidimacrin in human hepatoma HLE cells. Anticancer Res 29:1349–1354
230. Zhang Y, Talalay P, Cho CG, Posner GH (1992) A major inducer of anti-carcinogenic protective enzymes from broccoli: isolation and elucidation of structure. PNAS 89:2399–2403
231. Zhang SM, Hunter DJ, Rosner BA et al (2000) Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin’s lymphoma among women. Cancer Epidemiol Biomarkers Prev 9:477–485
232. Zhang W, Wang Z, Chen T (2011) Curcumol induces apoptosis via caspases-independent mitochondrial pathway in human lung adenocarcinoma ASTC-a-1 cells. Med Oncol 28:307–314
233. Zhao J, Wang J, Chen Y, Agarwal R (1999) Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two stage initiation-promotion protocol and identification of procyanidin B5–39-gallate as the most effective antioxidant constituent. Carcinogenesis 20:1737–1745
234. Zheng W, Dai Q, Custer L et al (1999) Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8:35–40
235. Zheng YP, Sun XY, Ba ZZ, Lin DH, Zhao F (2008) Antitumor activity of furanodiene in vivo and in vitro. J Yantai Univ (Natural Sci Eng Ed) 21:115–119
236. Zhong ZF, Li YB, Wang SP (2012) Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARg independent manner. J Cell Biochem 113:2643–2651
237. Zhou Y, Gao W, Li K (2008) Chinese herbal medicine in the treatment of lung cancer. AJTM 3:1–11
238. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW (1993) Migration patterns and breast cancer risk in Asian-American women. J Nat Cancer Inst 85:1819–1827
239. Zolfaghari B, Sadeghi M, Troiano R, Lanzotti V (2013) Vavilosides A1/A2-B1/B2, new furostane glycosides from the bulbs of Allium vavilovii with cytotoxic activity. Bioorg Med Chem 21:1905–1910